- Home
- ABCL vs BBOT Comparison
ABCL vs BBOT Comparison
Compare ABCL & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABCL | BBOT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABCL | BBOT |
|---|---|---|
| Price | $4.12 | $13.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $7.75 | ★ $23.80 |
| AVG Volume (30 Days) | ★ 3.5M | 232.3K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $35,325,000.00 | N/A |
| Revenue This Year | $25.45 | N/A |
| Revenue Next Year | $10.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.17 | N/A |
| 52 Week Low | $1.89 | $8.50 |
| 52 Week High | $6.52 | $14.87 |
Technical Indicators
Market Signals| Indicator | ABCL | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | N/A |
| Support Level | $3.34 | N/A |
| Resistance Level | $4.20 | N/A |
| Average True Range (ATR) | 0.21 | 0.00 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 88.37 | 0.00 |
Price Performance
Historical ComparisonAbout ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.